<p>Migration indices for THP-1 cells in response to hS100A8 (A), hS100A9 (B), and hS100A12 (C). Effects of anti-RAGE, anti-hTLR4 Abs and isotype control Abs on hS100A8 (D), hS100A9 (E) and hS100A12 (F) induced THP-1 cell migration. Serial dilution of anti-RAGE, anti-TLR4 or isotype-matched control Ab were incubated with THP-1 cells in the upper wells of the chemotaxis chamber, and optimal amounts of hS100A8 (1 ng/ml), hS100A9 (1 ng/ml) and hS100A12 (100 ng/ml) were added in the lower wells. Percentage inhibition is relative to no Ab treatment. One representative of three independent experiments is shown (mean ±SD of triplicate wells) (G) The effects of a fixed 10 μg/ml dose of anti-RAGE, anti-hTLR4 and control Abs on THP-1 cell migration me...
<p>The cell line co-expressing RAGE and the PAC1 receptor (PAC1/RAGE) was stimulated with PACAP-27, ...
<p>Data points in each figure represent the average value ± standard deviation of quadruplicate well...
The receptor for advanced glycation end products (RAGE) is a multi-ligand cell surface receptor and ...
<p>Chemotactic responses to S100A9 of human leukocyte populations were examined at the optimal conce...
<p>HUVECs were stimulated with S100A8 (2.0 µg/mL) (<b>A, D</b>), S100A9 (2.0 µg/mL) (<b>B, E</b>) an...
<p>Human PBMCs were stimulated with 10 μg/ml of human S100 preparations and levels of IL-6 (and othe...
<p>a: Direct blockade by a specific RAGE blocking antibody reduces cellular proliferation. RAGE depe...
<p>A: Binding of homo- and hetero-complexes of S100A4 and S100A9 to immobilized RAGE and TLR4. S100A...
<p>A) Dose-response activity of anti-RAGE (0.02–200 nM) on HUVEC migration. After starvation, cells ...
<p>A) Molecular interaction between S100A4 and RAGE by SPR. Overlayed sensorgrams of interaction bet...
<p><b>A–B.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for S...
<p>a: Rapid and transient induction of RAGE surface expression after stimulation with S100A8/A9. Nor...
<p><b>A–C.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for c...
<p>a: Spontaneous secretion of S100A8/A9 from normal and SCC-derived keratinocytes. Normal and SCC-d...
BACKGROUND: Expression of the small calcium-binding protein S100A4 is associated with poor prognosis...
<p>The cell line co-expressing RAGE and the PAC1 receptor (PAC1/RAGE) was stimulated with PACAP-27, ...
<p>Data points in each figure represent the average value ± standard deviation of quadruplicate well...
The receptor for advanced glycation end products (RAGE) is a multi-ligand cell surface receptor and ...
<p>Chemotactic responses to S100A9 of human leukocyte populations were examined at the optimal conce...
<p>HUVECs were stimulated with S100A8 (2.0 µg/mL) (<b>A, D</b>), S100A9 (2.0 µg/mL) (<b>B, E</b>) an...
<p>Human PBMCs were stimulated with 10 μg/ml of human S100 preparations and levels of IL-6 (and othe...
<p>a: Direct blockade by a specific RAGE blocking antibody reduces cellular proliferation. RAGE depe...
<p>A: Binding of homo- and hetero-complexes of S100A4 and S100A9 to immobilized RAGE and TLR4. S100A...
<p>A) Dose-response activity of anti-RAGE (0.02–200 nM) on HUVEC migration. After starvation, cells ...
<p>A) Molecular interaction between S100A4 and RAGE by SPR. Overlayed sensorgrams of interaction bet...
<p><b>A–B.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for S...
<p>a: Rapid and transient induction of RAGE surface expression after stimulation with S100A8/A9. Nor...
<p><b>A–C.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for c...
<p>a: Spontaneous secretion of S100A8/A9 from normal and SCC-derived keratinocytes. Normal and SCC-d...
BACKGROUND: Expression of the small calcium-binding protein S100A4 is associated with poor prognosis...
<p>The cell line co-expressing RAGE and the PAC1 receptor (PAC1/RAGE) was stimulated with PACAP-27, ...
<p>Data points in each figure represent the average value ± standard deviation of quadruplicate well...
The receptor for advanced glycation end products (RAGE) is a multi-ligand cell surface receptor and ...